Back to Trades
Shah Nikita
Executive Vice PresidentCIK 0001738061
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 1
- Active
- 2025–2026
Shah Nikita, Executive Vice President, has filed 5 SEC reports (2025–2026), all concentrated in Amneal Pharmaceuticals, Inc. (AMRX), totaling $7.1M in disclosed volume. Weighing $0 bought versus $6.4M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Aug 13 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $2.6M |
| Nov 14 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $1.6M |
| Aug 25 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $1.2M |
| Aug 15 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $666.0K |
| Aug 13 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $452.0K |
5 filings